SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-017565
Filing Date
2019-09-10
Accepted
2019-09-10 08:07:39
Documents
3
Period of Report
2019-09-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k091019c_delmarpharma.htm 8-K 26873
2 PRESS RELEASE OF DELMAR PHARMACEUTICALS, INC. ISSUED SEPTEMBER 10, 2019 f8k091019cex99-1_delmarphar.htm EX-99.1 26564
3 GRAPHIC ex99-1_01.jpg GRAPHIC 9686
  Complete submission text file 0001213900-19-017565.txt   68173
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 191084312
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1